Patent US4894443A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4894443A Expired / Lapsed US ⏱️ 0.0 years remaining

Toxin conjugates

Assignee: Novartis Vaccines and Diagnostics Inc
•
Filing: 1984-09-07
•
Granted: 1990-01-16
•
Expires: 2004-09-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel class of polypeptides of the general formula (F-(Pro)n)mF, wherein F represents a flexible amino acid sequence wherein each amino acid is individually selected from the group consisting of serine, glycine, and threonine, and n is an integer from 4-8 inclusive and m is an integer from 1-4 inclusive, is disclosed. Thses polypeptides are useful in the construction of conjugates between antibodies and peptide toxins. The preparation of such conjugate toxins by linking antibodies to toxin/spacer composites prepared by recombinant techniques is also disclosed.

Inventors

  • 👤 Lawrence I. Greenfield
  • 👤 Donald A. Kaplan
  • 👤 Danute E. Nitecki

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:48
CPC Classifications
A; A61; A61K; A61K39/00; A61K39/395; A61K39/44; A61K47/00; A61K47/50; A61K47/51; A61K47/68; A61K47/6801; A61K47/6803; A61K47/6811; A61K47/6817; A61K47/6835; A61K47/6851; A61K47/6855; A61K47/6889; C; C07; C07K; C07K14/00; C07K14/195; C07K14/34; C07K14/415; C07K16/00; C07K16/18; C07K16/28; C07K16/30; C07K16/3015; C07K17/00; C07K17/02; C07K17/06; C07K7/00; C07K7/04; C07K7/08; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/62; C12N15/63; C12N15/67; C12N15/69; C12N15/70; A61K38/00; C07K2319/00; C07K2319/33; Y; Y10; Y10S; Y10S530/00; Y10S530/82; Y10S530/825

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 39 words
A recombinant polypeptide, useful in making toxin conjugates, comprising: a diptheria toxin, or an enzymatic fragment of diptheria toxin; and a spacer covalently linked to said diptheria toxin comprising an amino acid sequence which has the formula: Gly-Thr-Gly-Ser-Gly-(Pro).sub.6 -Ser-Gly-Ser-Gly-Thr-Cys.
Claim 2
Dependent Claim 39 words
A recombinant polypeptide, useful in making toxin conjugates, comprising: a diptheria toxin, or an enzymatic fragment of diptheria toxin; and a spacer covalently linked to said diptheria toxin comprising an amino acid sequence which has the formula: Gly-Thr-Gly-Ser-Gly-(Pro).sub.6 -Ser-Gly-Ser-Gly-Thr-Cys.
Claim 3
Dependent Claim 45 words
A conjugated toxin comprising the recombinant polypeptide of claim 1 covalently linked to a binding moiety wherein said binding moiety is covalently linked to said spacer amino acid sequence and comprises an antibody or fragment thereof which is capable of binding to an antigenic determinant.
Claim 4
Independent Claim 94 words
A method of killing undesirable cells in mammals comprising administering to a mammal in need of such treatment an effective amount of a conjugated toxin comprising; an antibody or fragment thereof which binds to a target cell which comprises the corresponding antigenic determinant; and a recombinant protein comprising: a spacer covalently bound to said antibody or fragment thereof comprising an amino acid sequence which has the formula: Gly-Thr-Gly-Ser-Gly-(Pro).sub.6 -Ser-Gly-Ser-Gly-Thr-Cys; and a cytotoxic protein fragment covalently bound to said spacer selected from the group consisting of diptheria toxin and enzymatically active fragments of diptheria toxin.
Claim 5
Independent Claim 94 words
A method of killing undesirable cells in mammals comprising administering to a mammal in need of such treatment an effective amount of a conjugated toxin comprising; an antibody or fragment thereof which binds to a target cell which comprises the corresponding antigenic determinant; and a recombinant protein comprising: a spacer covalently bound to said antibody or fragment thereof comprising an amino acid sequence which has the formula: Gly-Thr-Gly-Ser-Gly-(Pro).sub.6 -Ser-Gly-Ser-Gly-Thr-Cys; and a cytotoxic protein fragment covalently bound to said spacer selected from the group consisting of diptheria toxin and enzymatically active fragments of diptheria toxin.

References Cited (Backward Citations)

US4340535A Cited
US4357273A Cited
US4350626A Cited
US4269764A Cited
US4379145A Cited
EP0044167A2 Cited
US4359457A Cited
US4363758A Cited
US4368149A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-01-15 1993-07-17 1994-01-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-01-15 1997-07-17 1998-01-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-01-15 2001-07-17 2002-01-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag